Phase 3 Alogliptin Pediatric Study

Clinical trial NCT02856113 · COMPLETED

Trial details

NCT number: NCT02856113
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2016-10-14
Primary completion: 2021-08-06
Enrollment: 152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.